Shock Patients and Enteral Nutrition?
DOI:
https://doi.org/10.54097/2frt1b93Keywords:
Enteral Nutrition, Feeding Intolerance, Risk FactorAbstract
Shock is a life-threatening condition characterized by microcirculatory disturbances and inadequate tissue perfusion. In hemodynamically unstable individuals, arterial pressure is maintained with vasoactive agents. Enteral nutrition (EN) is crucial for the intensive treatment of critically ill patients, facilitating intestinal recovery and improving clinical outcomes such as reducing infections, shortening hospital stays, and lowering costs. The impact of vasoactive agents on gastrointestinal blood flow varies, depending on the drug, dose, body size, and individual sensitivity. EN is categorized into early and delayed, and multiple guidelines recommend delayed EN due to the risks in the early stage, which may lead to EFI, non-obstructive mesenteric ischemia and necrosis. Guidelines for early EN in shock patients are still evolving, exploring the optimal timing and safety thresholds. Studies have shown that early EN can be safely implemented in hemodynamically stable patients maintaining a mean arterial pressure of 70 mmHg with stable doses of antihypertensives. This review summarizes the optimal and safe timing of initiating EN in shock patients to guide clinical practice. The pathophysiology of shock, EN selection, considerations, nutritional regimens, effects of antihypertensive agents, and feeding regimens are further discussed.
Downloads
References
[1] Kang W, Kudsk KA. Is there evidence that the gut contributes to mucosal immunity in humans? JPEN J Parenter Enteral Nutr. 2007; 31:246-258.
[2] Windsor AC, Kanwar S, Li AG, et al. Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis. Gut. 1998; 42:431-435.
[3] Ammori BJ, Leeder PC, King RF, et al. Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortality. J Gastrointest Surg. 1999; 3: 252-262.
[4] Berger MM, Revelly JP, Cayeux MC, Chiolero RL. Enteral nutrition in critically ill patients with severe hemodynamic failure after cardiopulmonary bypass. Clin Nutr 2005;24(1): 124-32.
[5] Turza KC, Krenitsky J, Sawyer RG. Enteral feeding and vasoactive agents: suggested guidelines for clinicians. Practical Gastroenterol 2009;33: 11e12þ5.
[6] Simon E, Călinoiu LF, Mitrea L, Vodnar DC. Probiotics, Prebiotics, and Synbiotics: Implications and Beneficial Effects against Irritable Bowel Syndrome. Nutrients. 2021 Jun 20;13(6):2112. doi: 10.3390/nu13062112. PMID: 34203002; PMCID: PMC8233736.
[7] Allen JM. Vasoactive substances and their effects on nutrition in the critically ill patient. Nutr Clin Pract 2012;27(3):335-9.
[8] Berger MM, Chiolero RL. Enteral nutrition and cardiovascular failure: from myths to clinical practice. JPEN - J Parenter Enter Nutr 2009;33(6):702-9.
[9] Taylor BE, McClave SA, Martindale RG, Warren MM, Johnson DR, Braunschweig C, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient. Crit Care Med 2016;44(2):390-438.
[10] Reintam Blaser A, Starkopf J, Alhazzani W, Berger MM, Casaer MP, Deane AM, et al. Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines. Intensive Care Med 2017;43(3):380-98.
[11] Singer P, Blaser AR, Berger MM, Alhazzani W, Calder PC, Casaer MP, et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr 2019;38(1):48-79.
[12] Merchan C, Altshuler D, Aberle C, Papadopoulos J, Schwartz D. Tolerability of enteral nutrition in mechanically ventilated patients with septic shock who require vasopressors. J Intensive Care Med 2016;32(9):540-6.
[13] Ohbe H, Jo T, Matsui H, Fushimi K, Yasunaga H. Differences in effect of early enteral nutrition on mortality among ventilated adults with shock requiring low-, medium-, and high-dose noradrenaline: a propensity-matched analysis. Clin Nutr 2020;39(2):460-7.
[14] Flordelís Lasierra JL, P erez-Vela JL, Umezawa Makikado LD, Torres Sanchez E, Colino G omez L, Maroto Rodríguez B, et al. Early enteral nutrition in patients with hemodynamic failure following cardiac surgery. J Parenter Enteral Nutr 2013;39(2):154-62.
[15] Ohbe H, Jo T, Yamana H, Matsui H, Fushimi K, Yasunaga H. Early enteral nutrition for cardiogenic or obstructive shock requiring venoarterial extracorporeal membrane oxygenation: a nationwide inpatient database study. Intensive Care Med 2018;44(8):1258e65.
[16] Mancl EE, Muzevich KM. Tolerability and safety of enteral nutrition in critically ill patients receiving intravenous vasopressor therapy. JPEN - J Parenter Enter Nutr 2013;37 (5):641-51.
[17] Patel JJ, Kozeniecki M, Peppard WJ, Peppard SR, Zellner-Jones S, Graf J, et al. Phase 3 pilot randomized controlled trial comparing early trophic enteral nutrition with "No enteral nutrition" in mechanically ventilated patients with septic shock. JPEN - J Parenter Enter Nutr 2020;44(5):866-73.
[18] Khalid I, Doshi P, DiGiovine B. Early enteral nutrition and outcomes of critically ill patients treated with vasopressors and mechanical ventilation. Am J Crit Care 2010;19(3):261-8.
[19] McClave SA, Chang W-K. Feeding the hypotensive patient: does enteral feeding precipitate or protect against ischemic bowel? Nutrition in clinical practice. Off Pub Am Soci Paren Ent Nutr 2003;18(4):279-84.
[20] Ortiz-Reyes, L., et al., Early versus delayed enteral nutrition in mechanically ventilated patients with circulatory shock: a nested cohort analysis of an international multicenter, pragmatic clinical trial. Crit Care, 2022. 26(1): p. 173.
[21] Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative workgroup. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the Acute Dialysis Quality Initiative (ADQI) group. Crit Care. 2004; 8(4): R204‐R212.
[22] Spanish Society of Intensive and Critical Medicine and Coronary Units (SEMICYUC). Definitions and Terms Manual. National Study of Nosocomial Infection Surveillance in ICU (ENVIN‐HELICS). Accessed October 21, 2020. http:// hws. vhebron. net/envin-helics/Help% 5CManual.pdf
[23] Reignier J, Boisramé‐Helms J, Brisard L, et al.; NUTRIREA‐2Trial Investigators; Clinical Research Intensive Care and Sepsis (CRICS) group. Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open‐label, parallel‐group study (NUTRIREA‐2). Lancet. 2018;391(10116):133‐143.
[24] Flordelis, L.J., et al., Enteral nutrition in critically ill patients under vasoactive drug therapy: The NUTRIVAD study. JPEN J Parenter Enteral Nutr, 2022. 46(6): p. 1420-1430.
[25] Berger MM, Chiolero RL. Enteral nutrition and cardiovascular failure: from myths to clinical practice. JPEN J Parenter Enteral Nutr. 2009; 33(6):702‐709.
[26] Nygren A, Thor en A, Ricksten S-E. Norepinephrine and intestinal mucosal perfusion in vasodilatory shock after cardiac surgery. Shock 2007;28(5): 536-43.
[27] Krejci V, Hiltebrand LB, Sigurdsson GH. Effects of epinephrine, norepinephrine, and phenylephrine on microcirculatory blood flow in the gastrointestinal tract in sepsis. Crit Care Med 2006;34(5).
[28] Reintam Blaser A, Starkopf J, Alhazzani W, Berger MM, Casaer MP, Deane AM, et al. Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines. Intensive Care Med 2017; 43:380‑98.
[29] Seguin P, Bellissant E, Le Tulzo Y, Laviolle B, Lessard Y, Thomas R, et al. Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock. Clin Pharmacol Ther 2002;71(5): 381-8.
[30] Nacul FE, Guia IL, Lessa MA, Tibirica E. The effects of vasoactive drugs on intestinal functional capillary density in endotoxemic rats: intravital videomicroscopy analysis. Anesth Analg 2010;110(2):547-54.
[31] McClave SA, Taylor BE, Martindale RG, Warren MM, Johnson DR, Braunschweig C, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: society of critical care medicine (SCCM) and American society for parenteral and enteral nutrition (ASP EN). J Parenter Enteral Nutr. (2016) 40:159211. doi: 10.1177/0148607115621863.
[32] Nygren A, Thor en A, Ricksten SE. Vasopressors and intestinal mucosal perfusion after cardiac surgery: norepinephrine vs. phenylephrine. Crit Care Med 2006;34(3):722-9.
[33] Birnbaum J, Klotz E, Spies CD, Lorenz B, Stuebs P, Hein OV, et al. Effects of dopexamine on the intestinal microvascular blood flow and leukocyte activation in a sepsis model in rats. Crit Care 2006;10(4): R117.
[34] Nevi ere R, Mathieu D, Chagnon JL, Lebleu N, Wattel F. The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients. Am J Respir Crit Care Med 1996;154(6 Pt 1):1684-8.
[35] Duranteau J, Sitbon P, Teboul JL, Vicaut E, Anguel N, Richard C, et al. Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock. Crit Care Med 1999;27(5): 893-900.
[36] Joly LM, Monchi M, Cariou A, Chiche JD, Bellenfant F, Brunet F, et al. Effects of dobutamine on gastric mucosal perfusion and hepatic metabolism in patients with septic shock. Am J Respir Crit Care Med 1999;160(6):1983-6.
[37] Reignier J, Boisram e-Helms J, Brisard L, Lascarrou J-B, Ait Hssain A, Anguel N, et al. Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled,multicentre,open-label,parallel-group study (NUTRIREA-2). Lancet 2018;391(10116):133-43
[38] Yang S, Wu X, Yu W, Li J. Early enteral nutrition in critically ill patients with hemodynamic instability: an evidence-based review and practical advice. Nutr Clin Pract 2014;29(1):90e6.
[39] Reignier J, Plantefeve G, Mira JP, Argaud L, Asfar P, Aissaoui N, et al. Low versus standard calorie and protein feeding in ventilated adults with shock: a randomised, controlled, multicentre, open-label,parallel-group trial (NUTRIREA-3). Lancet Respir Med 2023;11(7):602e12.
[40] Preiser, J.C., et al., A guide to enteral nutrition in intensive care units: 10 expert tips for the daily practice. Crit Care, 2021. 25 (1): p. 424.
[41] Flordelis Lasierra JL, Montejo Gonzalez JC, Lopez Delgado JC, Zarate Chug P, Martinez Lozano-Aranaga F, Lorencio Cardenas C, et al. Enteral nutrition in critically ill patients under vasoactive drug therapy: the NUTRIVAD study. JPEN - J Parenter Enter Nutr 2022;46(6):1420-30.
[42] Kozar RA, Hu S, Hassoun HT, DeSoignie R, Moore FA. Specific intraluminal nutrients alter mucosal blood flow during gut ischemia/reperfusion. JPEN - J Parenter Enter Nutr 2002; 26 (4):226-9.
[43] Kles KA, Wallig MA, Tappenden KA. Luminal nutrients exacerbate intestinal hypoxia in the hypoperfused jejunum. JPEN - J Parenter Enter Nutr 2001;25(5):246-53.
[44] Mentec H, Dupont H, Bocchetti M, Cani P, Ponche F, Bleichner G. Upper digestive intolerance during enteral nutrition in critically ill patients: frequency, risk factors, and complications. Crit Care Med 2001;29(10).
[45] Deane A, Chapman MJ, Fraser RJ, Bryant LK, Burgstad C, Nguyen NQ. Mechanisms underlying feed intolerance in the critically ill: implications for treatment. World J Gastroenterol 2007;13(29):3909e17.
[46] Bordeje ML, Montejo JC, Mateu ML, Solera M, Acosta JA, Juan M, et al. Intraabdominal pressure as a marker of enteral nutrition intolerance in critically ill patients. The PIANE study. Nutrients 2019;11(11).
[47] Mao Z, Liu G, Yu Q, Qi S, Lou Y, Liu C, et al. Association between serum lactate levels and enteral feeding intolerance in septic patients treated with vasopressors: a retrospective cohort study. Ann Transl Med 2020;8(19):1240.
[48] Macafee DAL, Allison SP, Lobo DN. Some interactions between gastrointestinal function and fluid and electrolyte homeostasis. Curr Opin Clin Nutr Metab Care 2005;8(2).
[49] Clair DG, Beach JM. Mesenteric ischemia. N Engl J Med 2016;374(10):959e68.
[50] Jia, K., X. Tong and F. Liang, Effects of sequential nutritional support on nutritional status and expression of regulatory T lymphocyte in patients with early severe traumatic brain injury. Neuropsychiatr Dis Treat, 2018. 14: p. 1561-1567.
[51] Flordelis Lasierra JL, Montejo Gonzalez JC, Lopez Delgado JC, Zarate Chug P, Martinez Lozano-Aranaga F, Lorencio Cardenas C, et al. Enteral nutrition in critically ill patients under vasoactive drug therapy: the NUTRIVAD study. JPEN - J Parenter Enter Nutr 2022;46(6):1420e30.
[52] Wang L, Zhang T, Yao H, Xu Q, Fu X, Yang J, et al. Association of vasopressors dose trajectories with enteral nutrition tolerance in patients with shock: a prospective observational study. Nutrients 2022;14(24).
[53] Schott U, Kander T. NOMI after cardiac arrest. Could refined diagnostics improve outcome? Resuscitation 2020; 157:266e8.
[54] Ewy, M., et al., Impact of Enteral Feeding on Vasoactive Support in Septic Shock: A Retrospective Observational Study. Nutr Clin Pract, 2020. 35(3): p. 540-547.
[55] Wanden-Berghe C, Patino-Alonso MC, Galindo-Villardón P, Sanz-Valero J. Complications Associated with Enteral Nutrition: CAFANE Study. Nutrients. 2019 Sep 1;11(9):2041. doi: 10.3390/nu11092041. PMID: 31480563; PMCID: PMC67 70113.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
